What does the IMRX options chain show right now?

As of Jun 30, 2026, Immuneering Corporation (IMRX) has 11.9K contracts outstanding and 125 traded today, with ATM IV of 100.1%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.

What expirations are available for IMRX options?

The nearest expiration is 17 days out, followed by 52 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.

How tight are IMRX options bid/ask spreads?

Average bid/ask spread across the chain is 67.73%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.

Immuneering Corporation (IMRX) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

Immuneering Corporation (IMRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $172.8M, listed on NASDAQ, employing roughly 54 people, carrying a beta of 0.38 to the broader market. Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Led by Benjamin J. Zeskind, public since 2021-07-30.

Snapshot as of Jun 30, 2026.

Spot Price: $4.91
Total OI: 11.9K
Total Volume: 125
Front Expiration: 17 days
Second Expiration: 52 days
ATM IV: 100.1%
Avg Bid/Ask Spread: 67.73%

As of Jun 30, 2026, Immuneering Corporation (IMRX) has 11.9K open contracts and 125 contracts traded. The nearest expiration is 17 days out, followed by 52 days. ATM implied volatility is 100.1%. Average bid/ask spread across the chain is 67.73%: wider spreads, size positions conservatively. The options chain aggregates every listed strike and expiration, letting traders evaluate skew, term structure, and liquidity in a single view.

How IMRX options chain Data Feeds Strategy Selection

Strategy selection on Immuneering Corporation options does not derive from any single metric in isolation. The options chain view above sits inside a broader read: ATM IV currently sits at 100.1% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options chain data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

How to read the IMRX chain depth

The listed-expirations table above shows every expiration available for Immuneering Corporation options with its days-to-expiration count and ATM implied volatility. Front-month expirations carry the most volume, the highest gamma, and the tightest bid-ask spreads; longer-dated tenors carry less liquidity but more vega exposure. IMRX front expiration sits at 17 days - the typical hedging horizon for monthly options. The backwardated slope of -0.183 means near-dated IV is pricing acute event risk.

IMRX chain mechanics and execution

Options are listed at standardized strike intervals (typically $1 for sub-$25 underlyings, $2.50-$5 for mid-cap, $10-$50 for large-cap), and the deltas of each listed strike are determined by where IV lies relative to the strike's moneyness. Average bid/ask spread on the IMRX chain is 67.73% - a measure of liquidity. Tighter spreads on liquid strikes mean lower transaction costs; wider spreads on long-dated or far-OTM strikes mean execution drag can dominate the math. The chain table on the SPA side shows the full per-strike, per-expiration grid; this SSR page summarizes the listed expirations and the front-month context to anchor the structural read.

Using the IMRX chain to build structures

Strategy selection starts with the chain: directional theses use single-leg calls or puts, range-bound theses use credit spreads or iron condors, vol theses use straddles or strangles, calendar theses use diagonal spreads. IMRX's current 28.70% expected move anchors wing placement - structures with wings at the implied band collect the modal-outcome premium under lognormal assumptions. Cross-reference with the gamma-exposure profile to understand where dealer hedging will reinforce or fight your position, and with the volatility-skew chart to confirm the strikes you're trading sit at the IV levels your strategy assumes.

Learn how the options chain is reported and how to read the data →

IMRX listed expirations

Per-expiration ATM implied volatility for IMRX options. Each row is one listed expiration with its days-to-expiration count and ATM IV pulled from the same term-structure feed that powers the SPA's expiration filter. Front-month expirations carry the highest gamma, the tightest bid-ask spreads, and the most volume; longer-dated tenors carry less liquidity but more vega.

Expiration	DTE	ATM IV
Jul 17, 2026	17	100.1%
Aug 21, 2026	52	81.8%
Nov 20, 2026	143	100.8%
Jan 15, 2027	199	108.6%
Feb 19, 2027	234	227.9%

Frequently asked IMRX options chain questions

What does the IMRX options chain show right now?: As of Jun 30, 2026, Immuneering Corporation (IMRX) has 11.9K contracts outstanding and 125 traded today, with ATM IV of 100.1%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.
What expirations are available for IMRX options?: The nearest expiration is 17 days out, followed by 52 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.
How tight are IMRX options bid/ask spreads?: Average bid/ask spread across the chain is 67.73%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.